AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg,
Published October 30, 2024 · Recall initiated: October 8, 2024
Summary
FDA records drug Class II recall D-0024-2025, published October 30, 2024 and initiated October 8, 2024. Recalling firm: C & A Naturistics; Status: Ongoing; Reported quantity: Unknown; Lot: All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- C & A Naturistics
- Distributor
- Nationwide within the United States
- Lot
- All Lots
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAThiamine HCl 0.9% Sodium Chloride Injection USP, 500 mg per 100 mL, Single Dose Bag, Rx only, Fagron SterileOctober 30, 2024
- FDAOneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle,October 30, 2024
- FDAEPINEPHrine 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL Single Dose Bag, Rx only, Fagron SterileOctober 30, 2024
- FDALactaid Lactose Reduced milk 1. 96 oz Lactaid Whole Milk 2. 96 oz Lactaid 2% Milk 3. 96oz Lactaid 1% Milk 4.October 30, 2024
- FDAOxytocin 0.9% Sodium Chloride Injection USP, 30 units per 500 mL Single Dose Bag, Rx only, Fagron SterileOctober 30, 2024
- FDAChois Kimchi Company Gluten Free Gochujang Red Chili Paste, packaged 16oz plastic pouch with spout, keepOctober 30, 2024
Questions about this recall
Was AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg, recalled?
Yes. FDA published recall D-0024-2025 on October 30, 2024. Reported hazard: Marketed without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared diclofenac and acetaminophen.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release